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252 The Journal of Thoracic and Cardbjective: Some patients with significant arteriosclerosis of the heart are not
menable to revascularization of a coronary artery because they have a combination
f microangiopathy and significant macroangiopathy. We investigated the benefit of
rterialization of a cardiac vein under these circumstances in an acute animal model.
ethods: In the hearts of 8 sheep, microspheres were injected into the left coronary
rtery; 60 minutes later, a stenosis of the left anterior descending artery was
erformed. After 45 minutes, retrograde venous revascularization was performed by
ewing the left internal thoracic artery to the concomitant vein of the left anterior
escending artery in a beating-heart technique. For flow reversal, the vein was
igated proximally to the anastomosis. The efficiency of the bypass graft was
valuated by coronary angiography and flow measurement. Cardiac output, elec-
rocardiography, and mean arterial blood pressure were assessed in each phase of the
xperiment.
esults: The ischemic state of the myocardium was confirmed by a significant
ecrease of cardiac output, stroke volume, and mean arterial blood pressure, and a
ignificant elevation of the ST segment in the electrocardiography. After retrograde
enous revascularization was established, cardiac output and stroke volume in-
reased and ST elevations decreased. The grafts showed adequate flow (26.15 
.08 mL/min), and reversed blood flow in the grafted vein was proved by coronary
ngiography.
onclusion: Retrograde venous revascularization is possible and improves cardiac
unction in a state of acute ischemia caused by a combination of microangiopathy
nd macroangiopathy.
espite constant advances in surgical and interventional therapy of coronary
artery disease, there remains a group of patients who are not amenable to
these traditional treatment strategies. Cardiologists meet this challenge by
ntroducing new therapeutic approaches such as the application of growth factors,
ene therapy, and methods of percutaneous venous revascularization.1-3 Cardiac
urgeons developed the technique of laser revascularization.4 There is another
echnical approach that was suggested by Pratt5 in 1898 and that found its way into
ractical use in coronary heart surgery for a short period of time in the 1970s: to
ourish the heart through the coronary veins. The results of experiments in animal
odels and outcome of follow-up examinations of patients who experienced venous
evascularization were as controversial as the opinions of surgeons about this
ethod.6-15 However, some patients who are not eligible for coronary artery bypass
rafting may be suitable for venous revascularization. Therefore, in this acute study
e created a coronary microangiopathy combined with the conditions of a coronary
acroangiopathy to investigate the benefit of the arterialization of a cardiac vein
iovascular Surgery ● May 2007
ub
a
M
E
e
w
s
c
s
t
p
p
i
a
p
v
fi
t
i
r
t
p
t
a
e
a
t
g
w
t
i
s
s
L
l
“
C
o
s
u
r
T
R
C
s
m
s
(
e
k
F
g
i
c
t
t
c
i
fi
a
T
b
fi
Resetar et al Surgery for Acquired Cardiovascular Disease
A
CDnder these circumstances, which has not been examined
efore (as a model for a patient with small-vessel disease
nd additional proximal stenosis).
aterials and Methods
ight sheep of both sex, weighing 60 to 65 kg, were used in the
xperiment. After induction of anesthesia the right femoral artery
as cannulated, the left coronary artery (LCA) was visualized by
tandard catheterization technique (Figure 1, A), and 8000 mi-
robeads (diameter: 100 m) in 5 mL of 0.9% sodium chloride
olution were injected into the LCA. During the next 60 minutes
hrough a median sternotomy, the left internal thoracic artery was
repared. A constantly inflated small balloon (volume: 4 mL) was
ut on the surface of the proximal part of the left anterior descend-
ng (LAD) artery and fixed by sutures stitched in the myocardium
round the vessel to induce stenosis greater than 65% by com-
ressing the LAD top down. (The degree of the stenosis was
erified by conventional heart catheterization technique.) Forty-
ve minutes after stenosis, the anastomosis of the left internal
horacic artery on the concomitant vein of the LAD was performed
n a beating-heart technique distally to the stenosis of the LAD. To
everse venous flow direction, the vein was ligated proximally to
he anastomosis. During the next 60 minutes, coronary angiogra-
hy and flow measurements of the bypass were performed. Finally
he LAD stenosis was reopened, and measurements were taken
fter 15 minutes.
The following parameters were assessed in each phase of the
xperiment: cardiac output (measured by a transonic flow probe
ttached to the ascending aorta), stroke volume, heart rate, elec-
rocardiogram (ECG), mean arterial pressure, and coronary an-
iography. Creatine kinase and cardiac specific creatine kinase
ere measured at the beginning of the experiment and after injec-
ion of the microspheres to reveal changes of the laboratory find-
ngs after this step. Digital subtraction angiography was used to
how the distribution of contrast agent at the different stages of the
tudy.
All experiments were approved by the Regierungspräsidium
eipzig, the institution of the University of Leipzig responsible for
aboratory animal care, and performed in accordance with the
Principles of Laboratory Animal Care” and the “Guide for the
are and Use of Laboratory Animals,” defined in the German law
f animal protection of 1998. All data are presented as mean 
tandard error of mean. Statistical evaluation was performed by
sing the Kolmogorov–Smirnov test followed by the Friedman
epeated-measures analysis of variance on ranks and Dunn’s test.
he paired t test was used for laboratory findings.
esults
ompared with baseline, the injection of microbeads re-
Abbreviations and Acronyms
ECG electrocardiogram
LAD left anterior descending
LCA left coronary arteryulted in a reduction of cardiac output, stroke volume, and D
The Journal of Thoracicean arterial pressure (Table 1). The heart rate stayed the
ame. The ECG showed an elevation of the ST segment
Figure 2, B) from baseline (Figure 2, A), and there was an
levation of creatine kinase and cardiac specific creatine
inase, which was significant for creatine kinase (Table 1).
igure 1. Angiograms taken during the experiment: The angio-
raphic catheter is introduced into the LCA where contrast fluid
s injected, which fills the LCA and its branches, the Ramus
ircumflexus, and the LAD without any pathologic changes (A) at
he beginning of the experiment and with stenosis (B). The
ransonic flow probe is placed on the ascending aorta, and a
atheter for measurement of changes of left ventricular volume is
ntroduced (not used in this experiment). C, The contrast fluid has
lled the left internal thoracic artery, and after passing the
nastomosis, the cardiac vein that accompanies the LAD artery.
here is a connection () of this vein with a venous vessel on the
ack of the heart (posterior cardiac vein). A clamp (C), used for
xation, is also visible. LCA, left coronary artery.igital subtraction angiography revealed a lesser content of
and Cardiovascular Surgery ● Volume 133, Number 5 1253
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A
CDontrast agent in the region supplied by the LCA after
njection of the microbeads.
Tightening a balloon on the LAD resulted in a stenosis of
0.88%  2.86% (Figure 1, B). It caused a significant
eduction of cardiac output, stroke volume, and mean arte-
ial pressure compared with baseline (Table 1). Heart rates
howed no significant changes. The ECG demonstrated a
ignificant progression of the elevation of ST segments from
aseline as well (Figure 2, C).
After arterialization of the cardiac vein was established,
ardiac output and stroke volume increased, approaching
ignificance (P  .08) (Table 1). Mean arterial pressure
ABLE 1. Trends of parameters during the experiment
arameter Baseline Microsp
ardiac output (L/min) 2.35 0.16 1.95
troke volume (mL/min) 22.13 1.43 20.06
eart rate (beats/min) 106.5 5.48 110.88
ean arterial pressure (torr) 78.25 4.25 69.25
reatine kinase (mol/L/s) 13.20 2.05 24.34
ardiac specific 6.66 0.50 7.19
reatine kinase (mol/L/s)
AD, Left anterior descending. Trends of parameters during the experime
ignificant change of value compared with the measurement at the begin
igure 2. Limb lead II is chosen to demonstrate the normal ECG at
he start of the experiment (A), the elevation of the ST segment
fter injection of the microspheres (B), its progression after
tenosis of the LAD artery (C), the regression of the ST segment
levations after establishing venous revascularization (D), and its
eturn to nearly normal after reopening the LAD artery (E). ECG,
lectrocardiogram; LAD, left anterior descending.d
254 The Journal of Thoracic and Cardiovascular Surgery ● Maecreased slightly but not significantly, as well as the heart
ate. In the ECG, ST segment elevations from baseline
howed a clear tendency of regression (Figure 2, D). Cor-
nary angiography showed the reversed blood flow in the
ardiac vein after arterialization (Figure 1, C). The bypass
rafts, with a flow of 26.15  2.08 mL/min, restored 77.5%
37.2% of the original cardiac function. (This statement is
ased on the following calculation: cardiac output and
troke volume were measured after venous revasculariza-
ion and after reopening of the LAD stenosis. Improvement
f values were compared, and the bypass on the cardiac vein
btained 77.5% of the improvement, which was achieved by
emoving the stenosis on the LAD.) Digital subtraction
ngiography images of the region, perfused by the bypass,
emonstrated restituted enrichment of contrast fluid.
Finally, release of the LAD stenosis resulted in complete
estoration of cardiac output and stroke volume, even at a
igher level than it was at the start of the experiment. Mean
rterial pressure decreased slightly, and the heart rate re-
urned to its basic value (Table 1). In the ECG, ST eleva-
ions from baseline showed a further regression to a level
etween the basic value at the start of the experiment and
he value measured after injection of the microbeads
Figure 2, E).
iscussion
n the past few decades, there has been in an increase in the
umber of patients with coronary heart disease who are not
ligible for standard procedures (eg, coronary artery bypass
rafting and percutaneous coronary angioplasty). Clinical
rials investigating treatment with angiogenesis factors and
ene therapy1 have been initiated, and new devices for
reating cardiac arteriovenous fistulas percutaneously2,3
ave been introduced. Whereas injection of growth factors
equires an adequate arterial inflow, which is often not
xistent in the hearts of these “no option patients,” new
atheter devices to create a fistula between a coronary artery
nd the accompanying vein or, as performed in animal
xperiments, a coronary vein and the left ventricle, are
Stenosis Bypass LAD open
1.7 0.19* 2.26 0.18 2.68  0.21
17.75  2.1* 24.88 2.45 26.25  1.83
102.63 6.08 93.38 5.16 106.88  6.87
59.13  3.74* 56.75 5.08 54.88  5.79
* / / /
/ / /
D). Data are presented as mean standard  error of mean. *There is a
of the experiment (P  .05).heres
0.12
1.94
3.94
2.74
3.57
0.63
nt (LAifficult to handle, may be expensive, and hold all the risks
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CDf catheterization of a severely altered vessel. In addition to
hese new procedures, the efficiency of which will have to
e investigated in long-term trials, we think that some
atients might profit from the revival of an “old” method:
etrograde venous revascularization. All previous animal
odels6-12,14,15 that systematically examined arterialization
f a cardiac vein imitated only the macroangiopathy of a
oronary artery. Therefore, we investigated the efficiency of
coronary venous bypass graft under the conditions of a
ombination of cardiac microangiopathy with a significant
acroangiopathic stenosis of a coronary artery, which is
requently found in diabetic angiopathy.
Our hypothesis, the creation of a model imitating an
cute ischemic situation caused by a combined angiopathy,
as supported by the observation of significant elevations
f ST segments in the ECG as a typical symptom of isch-
mia accompanied by a significant decrease of cardiac out-
ut, stroke volume, and mean arterial pressure. Digital sub-
raction angiography revealed a lesser content of contrast
gent in the affected myocardial region. We are aware that
n real disease the process of microangiopathy is more
omplex and involves surrounding tissue, but in our model,
s well as in the disease, capillary perfusion is reduced.
lso, other investigators have demonstrated that the injec-
ion of microbeads creates a significant change in heart
unction.16
After establishment of venous revascularization, the re-
ersal of blood flow in the vein connected to the arterial
raft was proved by the flow of contrast fluid. We suppose
hat the majority of the arterial blood provided by the bypass
essel reaches the capillary bed, nourishes the myocardium,6
nd drains through the arteriosinusoidal and thebesian ves-
els into the heart caves. The drainage could not be made
isible by the contrast fluid, probably because of the slow
assage of blood through these vessels. Digital subtraction
ngiography showed restituted enrichment of contrast fluid
n the region of the revascularized vein as a sign of im-
roved regional perfusion. Other indications of the effi-
iency of the coronary venous bypass graft are the regres-
ion of ST segment elevations in the ECG, as described
reviously,7 and the improvement of the hemodynamic sit-
ation. Stroke volume and cardiac output increased by im-
roving the contractility of the heart muscle and not by
ncreasing the heart rate, because this parameter did not
how any relevant changes through the whole experiment.
ean arterial blood pressure did not return to normal after
evascularization. This might be an effect of reactions of the
egetative nervous system and the long operation time with
n open chest, although we tried to prevent the status of
ypovolemia and its vegetative consequences by keeping
he central venous pressure in a certain range (10-12 torr)
hroughout the experiment. After the LAD was reopened,
ardiac output was even higher than its basic value at the
The Journal of Thoraciceginning. The reason for this may be a hyperemia caused
y retrograde venous revascularization. To sum up these
emodynamic parameters, the coronary venous bypass graft
ith an adequate flow restored 77.5%  37.2% of the
yocardial function compared with its basic value before
he ischemic state.
These observations suggest that retrograde venous revas-
ularization is a safe and efficient method to improve the
unction of a heart in an acute state of ischemia caused by
combination of macroangiopathy and microangiopathy.
owever, future studies are needed to investigate whether
his revascularization technique also leads to improvement
n a more chronic time scale and especially whether the
xygen supply during and apart from exercise can be main-
ained with this method. Only a long-term study on reste-
osis and functionality will establish whether this type of
evascularization may be as helpful as suggested by the
esults of the acute investigations and whether it could be
egarded not as an alternative to replace an aortocoronary
rtery bypass graft operation, if it is feasible, but as a last
herapeutic option for a group of patients who are not
ligible for any other standard procedure: patients with
mall vessel disease, diffuse arteriosclerosis, distal stenosis,
r dissected vessels, or patients who have undergone mul-
iple stenting of the coronaries.
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